Bio-Rad Laboratories, Inc. - Financials - Financial Results
BIO-RAD LABORATORIES, INC. General Corporate Statement (Form8) - Benzinga
Bio-Rad Announces the Global Launch of the CFX Opus 96 and CFX Opus 384 Real-Time PCR Systems and BR.io, Web-Based Data Management and Analysis Software | Bio-Rad
Leading Life Science Research & Clinical Diagnostics — Bio-Rad
Bio-Rad Offers Value If You Look (NYSE:BIO) | Seeking Alpha
December 2020 Update FINAL
Leading Life Science Research & Clinical Diagnostics — Bio-Rad
Bio-Rad Laboratories, Inc. - Financials - Financial Results
Bio-Rad Laboratories: More Growth Ahead (NYSE:BIO) | Seeking Alpha
Bio-Rad Laboratories: More Growth Ahead (NYSE:BIO) | Seeking Alpha
Bio-Rad Laboratories: More Growth Ahead (NYSE:BIO) | Seeking Alpha
Bio-Rad Laboratories, Inc. - Investor Relations
Bio-Rad Laboratories, Inc. - Financials - Financial Results
EX-99.1
December 2020 Update FINAL
Bio-Rad Laboratories, Inc.
Bio-Rad Will Grow In 2020 But Won't Match This Year's Stock Price Gains (NYSE:BIO) | Seeking Alpha
Bio-Rad Launches SEQuoia Express Stranded RNA Library Prep Kit at AGBT 2022 | Bio-Rad
Bio-Rad Laboratories, Inc. - Financials - Financial Results
Bio-Rad Presents Growth Strategy and Acceleration of Financial Targets at Investor Day
Immunohematology Testing with IH-Complete | Bio-Rad
Bio-Rad Laboratories, Inc. - Financials - Financial Results
Edward Chung - Vice President, Investor Relations - Bio-Rad Laboratories | LinkedIn
December 2020 Update FINAL
